In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

By Lobo Evelyn D.   Bergstrom Richard F.   Reddy Shobha   Quinlan Tonya   Chappell Jill   Hong Quan   Ring Barbara   Mary Pat Knadler  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 191-202

Adis International

Access to resources Recommend Favorite

CYTOCHROME P-450-MEDIATED DIFFERENTIAL OXIDATIVE MODIFICATION OF PROTEINS: ALBUMIN, APOLIPOPROTEIN E, AND CYP2E1 AS TARGETS

By Choi Dal   Leininger-Muller Brigitte   Wellman Maria   Kim Young   Siest Gerard  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 23-24, 2004-12 ,pp. : 2061-2071

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cytochrome P₄₅₀ 2C9 phenotyping using low-dose tolbutamide

By Jetter Alexander   Kinzig-Schippers Martina   Skott Andreas   Lazar Andreas   Tomalik-Scharte Dorota   Kirchheiner Julia   Walchner-Bonjean Monika   Hering Ursula   Jakob Verena   Rodamer Michael   Jabrane Wafaâ   Kasel Dirk   Brockmöller Jürgen   Fuhr Uwe   Sörgel Fritz  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 2A6 Phenotyping Based on Dietary Caffeine Intake in a Japanese Population of Non-smokers

By  

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-06 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of multiple cytochrome P450 activities in metabolically inactivated human liver microsomes and roles of P450 2C isoforms in reaction phenotyping studies

By  

Biopharmaceutics And Drug Disposition, Vol. 39, Iss. 2, 2018-02 ,pp. : 116-121

John Wiley & Sons Inc

Access to resources Recommend Favorite